Chrome Plugin Live! Redefine the way you read FinTwit š Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
IBER
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.22
+6743%
0.43
vsĀ -0.01
Q2.22
+2850%
0.18
vsĀ -0.01
Q3.22
+5%
0.11
vsĀ 0.1
Sales Growth
YoY
Current
Estimates
Q1.22
NA
NAĀ vsĀ NA
Q2.22
NA
NAĀ vsĀ NA
Q3.22
NA
NAĀ vsĀ NA
Return on Equity
QoQ
Q2.21
0%
-0.00
vsĀ -0.00
Q3.21
+1%
0.01
vsĀ -0.00
Q4.21
+1%
0.01
vsĀ 0.01
Q1.22
+6%
0.06
vsĀ 0.01
Q2.22
+2%
0.02
vsĀ 0.06
Q3.22
+1%
0.01
vsĀ 0.02
Institutionnal Ownership
QoQ
Q2.21
33
33
vsĀ NA
NA
Q3.21
39
39
vsĀ 33
18%
Q4.21
48
48
vsĀ 39
23%
Q1.22
49
49
vsĀ 48
2%
Q2.22
46
46
vsĀ 49
-6%
Q3.22
48
48
vsĀ 46
4%
Q4.22
48
48
vsĀ 48
NA
businesswire.com
8 hours ago
newsfilecorp.com
17 hours ago
prnewswire.com
18 hours ago
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
NYSE
-0.03Ā ( -0.29%)
Relative Strenght
Volume Buzz
-47%
Earning Acce
No
Dist 52w H.
5%Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How IBER compares to sector?
IBER
97x